EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke

Shuichi Fujiwara, Akiko Nakano-Doi, Toshinori Sawano iD, Shuji Kubo iD, Nobutaka Doe, Takayuki Nakagomi iD

Cells · 29.05.2024 · 13 (11) · 939

DOI: 10.3390/cells13110939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 29.05.2024. Verfasst von Shuichi Fujiwara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Advanced Medical Sciences, Hyogo Medical University (Nishinomiya Campus), 1-1 Mukogawacho, Nishinomiya 663-8501, Japan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neural Stem Cells, Mesenchymal Stem Cell Transplantation, Ischemic Stroke. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Japan Agency for Medical Research and Development (AMED), Japan Agency for Medical Research and Development (AMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increasing evidence shows that the administration of mesenchymal stem cells (MSCs) is a promising option for various brain diseases, including ischemic stroke. Studies have demonstrated that MSC transplantation after ischemic stroke provides beneficial effects, such as neural regeneration, partially by activating endogenous neural stem/progenitor cells (NSPCs) in conventional neurogenic zones, such as the subventricular and subgranular zones. However, whether MSC transplantation regulates the fate of injury-induced NSPCs (iNSPCs) regionally activated at injured regions after ischemic stroke remains unclear. Therefore, mice were subjected to ischemic stroke, and mCherry-labeled human MSCs (h-MSCs) were transplanted around the injured sites of nestin–GFP transgenic mice. Immunohistochemistry of brain sections revealed that many GFP+ cells were observed around the grafted sites rather than in the regions in the subventricular zone, suggesting that transplanted mCherry+ h-MSCs stimulated GFP+ locally activated endogenous iNSPCs. In support of these findings, coculture studies have shown that h-MSCs promoted the proliferation and neural differentiation of iNSPCs extracted from ischemic areas. Furthermore, pathway analysis and gene ontology analysis using microarray data showed that the expression patterns of various genes related to self-renewal, neural differentiation, and synapse formation were changed in iNSPCs cocultured with h-MSCs. We also transplanted h-MSCs (5.0 × 104 cells/µL) transcranially into post-stroke mouse brains 6 weeks after middle cerebral artery occlusion. Compared with phosphate-buffered saline-injected controls, h-MSC transplantation displayed significantly improved neurological functions. These results suggest that h-MSC transplantation improves neurological function after ischemic stroke in part by regulating the fate of iNSPCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsNeural Stem CellsMesenchymal Stem Cell TransplantationIschemic StrokeAnimalsHumansMiceCell DifferentiationMice, TransgenicMaleCell ProliferationNeurogenesisMice, Inbred C57BL

Stichwörter der Autor:innen

ischemic strokemesenchymal stem cellneural stem cellneurological functiontransplantation

Autor:innen und Institutionen

  • Institute for Advanced Medical Sciences, Hyogo Medical University (Nishinomiya Campus), 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
  • Department of Therapeutic Progress in Brain Diseases, Hyogo Medical University, 1-1 Mukogawacho, Nishinomiya 663-8501, Japan.
  • Department of Biomedical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu 525-8577, Japan.
  • Department of Rehabilitation, Hyogo Medical University (Kobe Campus), 1-3-6 Minatojima, Chuo-ku, Kobe 650-8530, Japan.

ORCID-Profile: Toshinori Sawano, Shuji Kubo, Takayuki Nakagomi

Förderung

  • the Japan Agency for Medical Research and Development (AMED)
  • Japan Agency for Medical Research and Development (AMED)

Zitieren

APA

Fujiwara, S., Nakano-Doi, A., Sawano, T., Kubo, S., Doe, N., & Nakagomi, T. (2024). Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke. Cells, 13(11), 939. https://doi.org/10.3390/cells13110939

Vancouver

Fujiwara S, Nakano-Doi A, Sawano T, Kubo S, Doe N, Nakagomi T. Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke. Cells. 2024;13(11):939. doi:10.3390/cells13110939

BibTeX
@article{Fujiwara2024,
  author = {Fujiwara, Shuichi and Nakano-Doi, Akiko and Sawano, Toshinori and Kubo, Shuji and Doe, Nobutaka and Nakagomi, Takayuki},
  title = {Administration of Human-Derived Mesenchymal Stem Cells Activates Locally Stimulated Endogenous Neural Progenitors and Reduces Neurological Dysfunction in Mice after Ischemic Stroke},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {939},
  doi = {10.3390/cells13110939}
}
Kostenlos starten →